Dual Blockade of the Renin-Angiotensin System in Glomerular Diseases
Author:
Affiliation:
1. Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Reference15 articles.
1. Saran R.; Li Y.; Robinson B.; US renal data system 2015 annual data report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 2016,67(3),A7-A8
2. Rovin B.H.; Adler S.G.; Barratt J.; KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 2021,100(4),S1-S276
3. Momoniat T.; Ilyas D.; Bhandari S.; ACE inhibitors and ARBs: Managing potassium and renal function. Cleve Clin J Med 2019,86(9),601-607
4. Mei M.; Zhou Z.; Zhang Q.; Chen Y.; Zhao H.; Shen B.; Dual blockade of the renin-angiotensin system: A strategy that should be reconsidered in cardiorenal diseases? Nephron J 2021,145(2),99-106
5. Zhao M.; Wang R.; Yu Y.; Efficacy and safety of angiotensin-converting enzyme inhibitor in combination with angiotensin-receptor blocker in chronic kidney disease based on dose: A systematic review and meta-analysis. Front Pharmacol 2021,12,638611
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3